Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OPKO Health Inc (NASDAQ:OPK)

7.83
Delayed Data
As of Apr 25
 +0.25 / +3.30%
Today’s Change
7.11
Today|||52-Week Range
12.15
-15.81%
Year-to-Date
Weekly CEO Buys Highlights
Apr 24 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close7.58
Today’s open7.56
Day’s range7.52 - 7.90
Volume3,486,499
Average volume (3 months)4,873,826
Market cap$4.4B
Dividend yield--
Data as of 04/25/2017

Growth & Valuation

Earnings growth (last year)+16.67%
Earnings growth (this year)-136.00%
Earnings growth (next 5 years)+40.10%
Revenue growth (last year)+148.44%
P/E ratioNM
Price/Sales4.19
Price/Book2.09

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...+1.05+2.09%
AGNPRAAllergan plc+3.35+0.40%
ACADACADIA Pharmaceutica...+0.99+2.94%
AKRXAkorn Inc+0.37+1.13%
Data as of 04/25/2017

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$1.2B
Annual profit (last year)-$25.1M
Net profit margin-2.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Phillip Frost
CFO, Treasurer, &
Chief Accounting Officer
Adam E. Logal
Corporate headquarters
Miami, Florida

Forecasts


Search for Jobs